Dietary supplement found to contain undeclared pharmaceutical drug tadalafil
Launch Sequence Capsules dietary supplement recalled for containing undeclared tadalafil, an FDA-approved pharmaceutical ingredient. The product was marketed without required drug approval.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall meets FDA Class I criteria, which establishes a minimum severity threshold of 4. The product contains an undeclared pharmaceutical ingredient marketed without required drug approval, posing serious regulatory and health hazards.
Plain-English summary
Launch Sequence Capsules, sold in 60-count bottles by Loud Muscle Science, are being recalled due to the presence of undeclared tadalafil. Tadalafil is an active pharmaceutical ingredient found in FDA-approved drugs used for male sexual enhancement.
The product was marketed as a dietary supplement without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA), making it an unapproved drug. This recall affects 5,421 bottles distributed nationwide in the USA and Canada, including Lot# 20212001 with an expiration date of 12/2024.
Consumers who have purchased this product should discontinue use immediately. Anyone who has consumed the product and experiences any adverse effects should consult a healthcare provider. The product should be returned to the point of purchase or disposed of properly.
The recalled product
- Product
- Launch Sequence Capsules, Dietary Supplement, 60- count bottles, ASIN B07TLPWXDS, UPC Code 641378938375.
- Manufacturer
- Loud Muscle Science
- Hazard
- undeclared-drug
- tadalafil
- unapproved-pharmaceutical
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 20212001
- Exp. Date 12/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27